Skip to main content
STEX
NASDAQ Industrial Applications And Services

Streamex Q2 Loss Narrows to $14.6M, But Cash Drops to $5.6M and Material Weaknesses Persist

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.99
Mkt Cap
$108.446M
52W Low
$0.655
52W High
$7.44
52W Position info
51% above low
Off High info
87% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

STEX sits 51% above its 52-week low of $0.655.

Summary

Streamex's Q2 loss narrowed to $14.6M, but cash dropped to $5.6M and material weaknesses persist. The company authorized a 10M share buyback and disclosed a $5M USDC loan to support GLDY liquidity.


Key Events · Earnings and Guidance · STEX

  • Q2 Loss Narrows

    Net loss of $14.6M for Q2 2026, down from $20.4M in Q2 2025, driven by lower stock-based compensation and first gold lease income of $146K.

  • Cash Burn Accelerates

    Cash fell to $5.6M from $20.3M at year-end 2025. Operating activities used $21.9M in H1 2026, though management says liquidity is sufficient for at least one year.

  • Material Weaknesses Persist

    Four material weaknesses in internal controls remain unremediated, including inadequate stock-based compensation recording and ineffective review processes.

  • Buyback Authorized

    Board authorized repurchase of up to 10M shares at a maximum price of $2.00 per share on July 1, 2026. No shares have been repurchased yet.


Analysis · STEX · Industrial Applications And Services

Streamex reported a narrower Q2 loss of $14.6 million versus $20.4 million a year ago, but the six-month loss ballooned to $61.2 million, driven by heavy stock-based compensation and debt extinguishment costs. Cash fell to $5.6 million from $20.3 million at year-end, though management says liquidity is sufficient for at least a year. The company also disclosed that material weaknesses in internal controls remain unremediated, and it authorized a 10-million-share buyback at up to $2.00 per share — a move that could support the stock but also signals confidence in its liquidity position. The filing also reveals a $5 million USDC loan to a trading firm to support GLDY liquidity, which carries counterparty risk.

At the time of this filing, STEX was trading at $0.99 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $108.4M. The 52-week trading range was $0.66 to $7.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

STEX - Latest Insights

STEX
Jul 13, 2026, 5:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.8445
Real-time Price: $0.960 info
Change: +$0.1155 (+14%) info
Market Cap: $108.446M info
STEX
Jul 07, 2026, 7:51 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $0.960 info
Change: -$0.160 (-14%) info
Market Cap: $108.446M info
STEX
May 28, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.52
Real-time Price: $0.960 info
Change: -$0.560 (-37%) info
Market Cap: $108.446M info
STEX
May 27, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.40
Real-time Price: $0.960 info
Change: -$0.4421 (-32%) info
Market Cap: $108.446M info
STEX
May 21, 2026, 4:47 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $0.960 info
Change: -$0.240 (-20%) info
Market Cap: $108.446M info